| In-hospital mortality | Overall cohort | |
---|---|---|---|
Yes (N = 17) | No (N = 56) | N = 73 | |
Age* | 66.3 (12.9) | 60.2 (14.7) | 60.7 (15.6) |
Female | 4 (23, 1–46) | 24 (43, 31–57) | 28 (38, 28–51) |
ED systolic BP | 102 (33) | 103.5 (39) | 103 (37) |
ED diastolic BP | 66 (24) | 68.0 (27) | 64.7(27) |
ED heart rate* | 104 (21) | 103 (24) | 103 (23) |
ED respiratory rate | 20 (4) | 20 (6) | 20 (6) |
ED Sp02 | 98 (3) | 98 (4) | 98 (3) |
ED temperature | 36.9 (2) | 36.9 (1.2) | 36.9 (1.5) |
Weight (kg)* | 70.6 (12.3) | 74.5 (17.1) | 74.9 (17.3) |
Past medical history | Â | ||
 Diabetes | 10 (59, 36–78) | 21 (38, 26–51) | 31 (42, 32–54) |
 Stroke | 5 (29, 13–53) | 11 (20, 11–32) | 16 (22, 14–33) |
 End-stage renal disease | 6 (35, 17–59) | 13 (23, 14–36) | 19 (26, 17–37) |
 Coronary artery disease | 4 (24, 10–47) | 14 (25, 15–38) | 18 (25, 16–36) |
 Cancer | 9 (53, 31–73) | 17 (30, 19–43) | 26 (36, 26–47) |
 COPD/asthma | 4 (24, 10–47)) | 12 (21, 12–34) | 16 (22, 14–33) |
 Heart failure (pEF or rEF) | 5 (29, 13–53) | 9 (16, 9–28) | 14 (19, 12–30) |
Laboratory results and interventions | Â | ||
 ED Lactate (mmol/L) | 4.3 (2.9) | 2.9 (1.9) | 3.1 (2) |
 ED Troponin-I (ng/mL) | 0.07 (0.07) | 0.05 (0.05) | 0.06 (0.05) |
 NT-pro BNP (pg/mL) | 1562 (0) | 135.5 (107) | 180 (555) |
 Hemoglobin (mg/dL) | 10.4 (2.55) | 11.2 (4.1) | 11 (3.3) |
 Creatinine (mg/dL) | 2.69 (2.77) | 2.05 (3.04) | 2.06 (2.76) |
 IVF 3 h (L) | 2.0 (1.5) | 2.0 (2.0) | 2.0 (2.0) |
 IVF 24 h (ml) | 3600 (2800) | 3145 (3100) | 4.5 (3.0) |
 30 cc/kg in 1st 3 h | 10 (59, 30–90) | 28 (58, 37–65) | 38 (52, |
 SOFA score: ED | 5 (4) | 3 (5) | 3 (5) |
 SOFA score: 24 h | 6.5 (7) | 2 (5) | 3 (5) |
 Mechanical ventilation | 9 (53, 31–74) | 10 (18, 10–30) | 19 (26, 17–37) |
 Vasopressor use | 9 (53, 31–74) | 10 (18, 10–30) | 19 (26, 17–37) |
 Days in Hospital | 6 (10) | 7 (7) | 6.5 (7.0) |
Primary source of infection# (%, N) | Â | ||
 Pneumonia | 41 (7) | 34 (19) | 36 (26) |
 GI/GU | 35 (6) | 38 (21) | 37 (27) |
 Skin/soft tissue/bone | 6 (1) | 3 (2) | 4 (3) |
 Other | 18 (3) | 25 (14) | 23 (17) |